The FDA unexpectedly approved the old chemotherapy drug leucovorin as a treatment for some individuals with autism, deviating from its usual rigorous review process, which has raised concerns among experts about the potential for hype and the narrowing of the drug's scope.
The National Hydropower Association and energy developers are warning that the regulatory process for new and existing hydropower projects is too burdensome, putting a reliable source of electricity for millions at risk. Hydropower supplies nearly 80,000 megawatts of the nation's power, but stakeholders argue it faces regulatory hurdles far greater than those facing other carbon-free sources of electricity. Without permitting reform that streamlines hydropower relicensing and licensing, facilities may be forced to shut down and energy developers may seek to invest elsewhere, jeopardizing the power of tens of millions of Americans.
JPMorgan Chase CEO Jamie Dimon has warned that the banking crisis caused by two bank failures in the US last month is still a threat and will have repercussions for years to come. He called for a reimagining of the regulatory process and cautioned against knee-jerk changes to the system. Dimon also stressed the importance of strengthening smaller banks for the benefit of the whole financial system and called for more forward-looking regulation. He also touched on the need for investments in climate technology and resiliency programs and the rise of artificial intelligence.